45 research outputs found
Dual Grid Voltage Modulated Direct Power Control of Grid-Connected Voltage Source Converter under Unbalanced Network Condition
Biological analysis of the potential pathogenic mechanisms of Infectious COVID-19 and Guillain-Barré syndrome
BackgroundGuillain-BarrĂ© syndrome (GBS) is a medical condition characterized by the immune system of the body attacking the peripheral nerves, including those in the spinal nerve roots, peripheral nerves, and cranial nerves. It can cause limb weakness, abnormal sensations, and facial nerve paralysis. Some studies have reported clinical cases associated with the severe coronavirus disease 2019 (COVID-19) and GBS, but how COVID-19 affects GBS is unclear.MethodsWe utilized bioinformatics techniques to explore the potential genetic connection between COVID-19 and GBS. Differential expression of genes (DEGs) related to COVID-19 and GBS was collected from the Gene Expression Omnibus (GEO) database. By taking the intersection, we obtained shared DEGs for COVID-19 and GBS. Subsequently, we utilized bioinformatics analysis tools to analyze common DEGs, conducting functional enrichment analysis and constructing Proteinâprotein interaction networks (PPI), Transcription factors (TF) -gene networks, and TF-miRNA networks. Finally, we validated our findings by constructing the Receiver Operating Characteristic (ROC) curves.ResultsThis study utilizes bioinformatics tools for the first time to investigate the close genetic relationship between COVID-19 and GBS. CAMP, LTF, DEFA1B, SAMD9, GBP1, DDX60, DEFA4, and OAS3 are identified as the most significant interacting genes between COVID-19 and GBS. In addition, the signaling pathway of NOD-like receptors is believed to be essential in the link between COVID-19 and GBS
SRSF5âMediated Alternative Splicing of M Gene is Essential for Influenza A Virus Replication: A HostâDirected Target Against Influenza Virus
Abstract: Splicing of influenza A virus (IAV) RNA is an essential process in the viral life cycle that involves the coâopting of host factors. Here, it is demonstrated that induction of host serine and arginineârich splicing factor 5 (SRSF5) by IAV facilitated viral replication by enhancing viral M mRNA splicing. Mechanistically, SRSF5 with its RRM2 domain directly bounds M mRNA at conserved sites (M mRNA position 163, 709, and 712), and interacts with U1 small nuclear ribonucleoprotein (snRNP) to promote M mRNA splicing and M2 production. Mutations introduced to the three binding sites, without changing amino acid code, significantly attenuates virus replication and pathogenesis in vivo. Likewise, SRSF5 conditional knockout in the lung protects mice against lethal IAV challenge. Furthermore, anidulafungin, an approved antifungal drug, is identified as an inhibitor of SRSF5 that effectively blocks IAV replication in vitro and in vivo. In conclusion, SRSF5 as an activator of M mRNA splicing promotes IAV replication and is a hostâderived antiviral target
Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs
Body-protective compound (BPC) 157 demonstrates protective effects against damage to various organs and tissues. For future clinical applications, we had previously established a solid-phase synthesis process for BPC157, verified its biological activity in different wound models, and completed preclinical safety evaluations. This study aimed to investigate the pharmacokinetics, excretion, metabolism, and distribution profiles of BPC157. After a single intravenous (IV) administration, single intramuscular (IM) administrations at three doses in successive increments along with repeated IM administrations, the elimination half-life (t1/2) of prototype BPC157 was less than 30Â min, and BPC157 showed linear pharmacokinetic characteristics in rats and beagle dogs at all doses. The mean absolute bioavailability of BPC157 following IM injection was approximately 14%â19% in rats and 45%â51% in beagle dogs. Using [3H]-labeled BPC157 and radioactivity examination, we proved that the main excretory pathways of BPC157 involved urine and bile. [3H]BPC157 was rapidly metabolized into a variety of small peptide fragments in vivo, thus forming single amino acids that entered normal amino acid metabolism and excretion pathways. In conclusion, this study provides the first analysis of the pharmacokinetics of BPC157, which will be helpful for its translation in the clinic
An Investigation on Chinese Public Acceptance of COVID-19 Prevention Measures
China has basically succeeded in bringing the COVID-19 epidemic under control, thanks to a timely series of effective prevention and control measures taken by the Chinese government. In this study, a public acceptance questionnaire of epidemic prevention measures was designed to investigate the influencing factors of public acceptance. A total of 2062 samples were collected from 8 March 2020 to 9 April 2020, and Independent-Samples T-Test and One-way ANOVA were used to analyze the data collected in the questionnaire in SPSS version 22.0. The results show that age and educational level have a significant influence on public acceptance. With the development of the epidemic, the acceptability grew generally higher. The public acceptance of traffic measures is the highest. This study summarises China’s scientific experience in the fight against COVID-19 and the differences in public acceptance. It can provide a positive reference for the development of epidemic prevention in other countries